Myomo (MYO) Income from Non-Controlling Interests (2019)
Myomo posted quarterly Income from Non-Controlling Interests of -$2.8 million for Q4 2019, up 0.95% on a QoQ basis from -$2.8 million in Q3 2019.
Myomo (MYO) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$2.8 million in Q4 2019.
- For the quarter ending Q4 2019, Income from Non-Controlling Interests changed N/A year-over-year to -$2.8 million; the trailing twelve-month figure through Dec 2019 stood at -$11.5 million (changed N/A YoY), and the FY2019 full-year result was -$11.5 million, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q4 2019 stood at -$2.8 million, up from -$2.8 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$2.6 million in Q2 2019 and bottomed at -$3.4 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -2.76 Mn |
| Sep 30, 2019 | -2.79 Mn |
| Jun 30, 2019 | -2.57 Mn |
| Mar 31, 2019 | -3.40 Mn |